SCHEMBL3433024

SCHEMBL3433024

COc1ccc(N(Cc2ccc(OCC([NH])=O)cc2)C(=O)OCC2c3ccccc3-c3ccccc32)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.39
▸ RAB9A P51151 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ FABP5 Q01469 1/20 0.38
▸ POLB P06746 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ TSHR P16473 3/20 0.35
▸ HTT P42858 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GPR55 Q9Y2T6 1/20 0.34
▸ BMP1 P13497 1/20 0.34
▸ LPAR1 Q92633 1/20 0.34
▸ LPAR2 Q9HBW0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28069712 0.89 FABP5 (0.45) RAB9ANPC1FABP5ALDH1A1LMNA
SCHEMBL17500350 0.89 NPC1 (0.43) HSD17B10RAB9ANPC1FABP5POLB
SCHEMBL303625 0.88 NPC1 (0.42) HSD17B10RAB9ANPC1FABP5POLB
SCHEMBL4841403 0.88 NPC1 (0.42) HSD17B10RAB9ANPC1FABP5POLB
SCHEMBL4784032 0.88 FABP5 (0.41) RAB9AFABP5TDP1ALDH1A1TSHR
SCHEMBL208874 0.88 FABP5 (0.41) RAB9AFABP5MAPK1ALDH1A1TSHR
SCHEMBL3499128 0.88 HSD17B10 (0.36) HSD17B10RAB9ANPC1FABP5POLB
SCHEMBL1526171 0.87 FABP5 (0.40) RAB9AFABP5MAPK1ALDH1A1TSHR
SCHEMBL5670740 0.87 FABP5 (0.39) RAB9AFABP5MAPK1ALDH1A1TSHR
SCHEMBL6298094 0.86 FABP5 (0.42) HSD17B10FABP5TDP1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268050-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. Lundbeck A/S (DK) 2003-01-02 — — EP claimed
WO-2001068598-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. LUNDBECK A/S (DK) 2001-09-20 — — WO claimed
EP-1053001-B1 NOVEL MIXED AMYLIN ACTIVITY COMPOUNDS AMYLIN PHARMACEUTICALS INC (US) 2010-12-15 — — EP disclosed
EP-1053001-A4 NOVEL MIXED AMYLIN ACTIVITY COMPOUNDS AMYLIN PHARMACEUTICALS INC (US) 2006-01-04 — — EP disclosed
EP-1268050-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. Lundbeck A/S (DK) 2003-01-02 — — EP disclosed
WO-2001068598-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. LUNDBECK A/S (DK) 2001-09-20 — — WO disclosed
EP-1053001-A1 NOVEL MIXED AMYLIN ACTIVITY COMPOUNDS AMYLIN PHARMACEUTICALS, INC. (US) 2000-11-22 — — EP disclosed
WO-1999040928-A1 NOVEL MIXED AMYLIN ACTIVITY COMPOUNDS AMYLIN PHARMACEUTICALS, INC. (US) 1999-08-19 — — WO disclosed
Send feedback